- Home
- Publications
- Publication Search
- Publication Details
Title
Is an enzyme supplement for celiac disease finally on the cards?
Authors
Keywords
-
Journal
Expert Review of Gastroenterology & Hepatology
Volume 12, Issue 6, Pages 531-533
Publisher
Informa UK Limited
Online
2018-05-07
DOI
10.1080/17474124.2018.1473762
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomised, double-blind, cross-over trial to evaluate bread, in which gluten has been pre-digested by prolyl endoprotease treatment, in subjects self-reporting benefits of adopting a gluten-free or low-gluten diet
- (2018) Dinka Rees et al. BRITISH JOURNAL OF NUTRITION
- Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity
- (2018) Gry I. Skodje et al. GASTROENTEROLOGY
- No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease
- (2017) Joseph A. Murray et al. GASTROENTEROLOGY
- Randomized clinical trial: Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting
- (2017) Julia König et al. Scientific Reports
- Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease
- (2016) Melanie Uhde et al. GUT
- Randomised clinical study:Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers
- (2015) B. N. Salden et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adverse Effects of Wheat Gluten
- (2015) Frits Koning ANNALS OF NUTRITION AND METABOLISM
- Small Amounts of Gluten in Subjects With Suspected Nonceliac Gluten Sensitivity: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial
- (2015) Antonio Di Sabatino et al. Clinical Gastroenterology and Hepatology
- Influence of dietary components on Aspergillus niger prolyl endoprotease mediated gluten degradation
- (2015) Veronica Montserrat et al. FOOD CHEMISTRY
- Nonceliac Gluten Sensitivity
- (2015) Alessio Fasano et al. GASTROENTEROLOGY
- Engineering of Kuma030: A Gliadin Peptidase That Rapidly Degrades Immunogenic Gliadin Peptides in Gastric Conditions
- (2015) Clancey Wolf et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Ineffective Degradation of Immunogenic Gluten Epitopes by Currently Available Digestive Enzyme Supplements
- (2015) George Janssen et al. PLoS One
- Glutenase ALV003 Attenuates Gluten-Induced Mucosal Injury in Patients With Celiac Disease
- (2014) Marja-Leena Lähdeaho et al. GASTROENTEROLOGY
- Diets that differ in their FODMAP content alter the colonic luminal microenvironment
- (2014) Emma P Halmos et al. GUT
- No Effects of Gluten in Patients With Self-Reported Non-Celiac Gluten Sensitivity After Dietary Reduction of Fermentable, Poorly Absorbed, Short-Chain Carbohydrates
- (2013) Jessica R. Biesiekierski et al. GASTROENTEROLOGY
- Consumption of gluten with gluten-degrading enzyme by celiac patients: A pilot-study
- (2013) Greetje J Tack WORLD JOURNAL OF GASTROENTEROLOGY
- Screening for Celiac Disease in a North American Population: Sequential Serology and Gastrointestinal Symptoms
- (2011) Kent D Katz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Gluten Causes Gastrointestinal Symptoms in Subjects Without Celiac Disease: A Double-Blind Randomized Placebo-Controlled Trial
- (2011) Jessica R Biesiekierski et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Differential Mucosal IL-17 Expression in Two Gliadin-Induced Disorders: Gluten Sensitivity and the Autoimmune Enteropathy Celiac Disease
- (2009) Anna Sapone et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- A Food-Grade Enzyme Preparation with Modest Gluten Detoxification Properties
- (2009) Jennifer Ehren et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More